[
    [
        {
            "time": "2018-03-15",
            "original_text": "Eli Lilly's Blockbuster Resurrection Story Has Holes",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Blockbuster",
                    "Resurrection",
                    "Holes"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly's Blockbuster Resurrection Story Has Holes",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-16",
            "original_text": "Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug",
            "features": {
                "keywords": [
                    "Gilead",
                    "shares",
                    "drop",
                    "FDA",
                    "concerns",
                    "Eli Lilly",
                    "Incyte",
                    "drug"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-17",
            "original_text": "Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Incyte",
                    "shares",
                    "fall",
                    "FDA",
                    "issues",
                    "rheumatoid",
                    "arthritis",
                    "drug"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-18",
            "original_text": "FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug",
            "features": {
                "keywords": [
                    "FDA",
                    "staff",
                    "safety",
                    "issues",
                    "Lilly",
                    "Incyte",
                    "rheumatoid",
                    "arthritis",
                    "drug"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA staff cites safety issues for Lilly, Incyne's rheumatoid arthritis drug",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "ANIP, CMD Get FDA Nod, BMY Seeks New Use For Opdivo, Eloxx On Watch",
            "features": {
                "keywords": [
                    "ANIP",
                    "CMD",
                    "FDA",
                    "Nod",
                    "BMY",
                    "Opdivo",
                    "Eloxx",
                    "Watch"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "ANIP, CMD Get FDA Nod, BMY Seeks New Use For Opdivo, Eloxx On Watch",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]